H|T: The Healthtech Times – Maple targets US, not public markets

The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using the form at the bottom of this page to ensure you don’t miss out on the most important healthtech news every week!


Maple looks beyond public markets for growth and scale (BETAKIT)

In an interview with BetaKit, Maple co-founder and CEO Dr. Brett Belchetz laid out his vision for the company, including continued expansion into the United States and becoming an all-in-one platform for virtual care.


RECOMMENDED BY MCI ONEHEALTH:

How tech can promote a collaborative, patient-centric approach in healthcare

“Innovation is not just about technology. It’s the mechanism by which you organize and sequence how you actually deliver healthcare, and how to actually understand the patient-doctor relationship.”

In an interview with BetaKit, Saleema Khimji, the Chief Innovation Officer at MCI Onehealth, shared how the current siloed ecosystem of researchers, governments, and private sector companies can fail patients – and why a new patient-centric model based on collaboration needs technology to thrive.

READ MORE


SonderMind reaches unicorn status as mental-health bets surge (BNN BLOOMBERG)

The fundraising values the Denver-based company at more than $1.1 billion, people with knowledge of the matter said.


Lumira Ventures closes $276 million CAD for fourth fund (BETAKIT)

Collectively, Lumira has secured over $320 million CAD for the two funds.


Exo secures $200M toward commercializing ultrasound device (TECHCRUNCH)

The new funding gives the Redwood City, California-based company over $320 million in total investments since the company was founded in 2015, Exo CEO Sandeep Akkaraju told TechCrunch.


Deep Genomics secures $226 million CAD led by SoftBank as it scales AI drug discovery platform (BETAKIT)

The round brings Deep Genomics’ total funding to date to around $302 million CAD.


Epic’s AI algorithms, shielded from scrutiny by a corporate firewall, are delivering inaccurate information on seriously ill patients (STAT NEWS)

Employees of several major health systems said they were particularly concerned about Epic’s algorithm for predicting sepsis.


Silofit secures $15.25 million CAD to bring micro-gym model to United States (BETAKIT)

The all-equity round, which did not involve any secondary capital, was led by previous investor Whitecap Venture Partners.


Elon Musk’s brain computer startup raises $205 million from Google Ventures and others (CNBC)

Founded in 2016, Neuralink is trying to develop high-bandwidth brain implants that can communicate with phones and computers.


MindBeacon sees revenue increase in Q2 as it ramps up for international expansion (BETAKIT)

In the company’s second earnings report since going public on the Toronto Stock Exchange (TSX) in December, MindBeacon saw its revenue, gross profit, and net loss increase amid a growing demand for mental health services during COVID-19.


Amwell to scoop up SilverCloud Health, Conversa Health for $320M (MED CITY NEWS)

The acquisitions will expand Amwell’s virtual care offerings and client base, with SilverCloud Health bringing digital behavioral health programs to its roster and Conversa Health adding text-based patient communications.


Avera Health sells off telemedicine services unit to Aquiline Capital Partners (FIERCE HEALTHCARE)

Avera Health has sold off Avera eCare, its telemedicine services unit, to private investment firm Aquiline Capital Partners for an undisclosed sum.


WELL Health launches venture arm, announces investment in Bright (BETAKIT)

The deal is one of the latest in a long line of acquisitions for WELL, which has previously acquired Ontario’s Intrahealth, Ottawa-based ExecHealth, Vancouver’s CRH Medical, and Toronto-based Adracare.


Report: Telehealth funding hits record high of $5B (MED CITY NEWS)

In addition, six telehealth companies joined the unicorn club, including LetsGetChecked and Thirty Madison.


0 replies on “H|T: The Healthtech Times – Maple targets US, not public markets”